The Nasdaq US Smart Pharmaceuticals Index is designed to provide exposure to US companies within the Pharmaceutical sector. The universe is screened by a series of three factors (Volatility, Value, and Growth). Securities are then selected and a modified factor weighted methodology is applied.
The Index began on July 8, 2016 at a base value of 1000.00.
|First Trust Nasdaq Pharmaceuticals||FTXH||First Trust Advisors L.P.|